Mode
Text Size
Log in / Sign up
N/A N=245 Randomized Double-blind Health Services Research

Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status

Tobacco Dependence

Enrolled (actual)
245
Serious AEs
9.0%
Results posted
Mar 2019
Primary outcome: Primary: Number of Participants Who Dropped Out of Study as a Measure of Adherence — 52; 19 Participants — p=<0.0001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Reduced Nicotine Content Cigarettes (Drug); Same Nicotine Content Cigarettes (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Milton S. Hershey Medical Center
Primary completion
Jan 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Who Dropped Out of Study as a Measure of Adherence
52; 19 <0.0001 sig
SECONDARY
Predictors of Participant Dropout
52; 19; 20; 14; 15; 18 <0.0001 sig
SECONDARY
Cigarettes Per Day
21.0; 25.1 0.0006 sig
SECONDARY
Nicotine Exposure
128.6; 265.3 <.0001 sig
SECONDARY
Smoke Exposure
27.2; 31.2 0.0305 sig
SECONDARY
Perceived Stress
12.9; 11.1 0.0207 sig
SECONDARY
Cortisol
0.32; 0.48 0.4191

Summary

The overall goal of this study is to address the question of whether progressively lowering nicotine content in cigarettes can reduce or eliminate nicotine dependence in smokers of low socioeconomic status

Eligibility Criteria

Inclusion Criteria

  • Age 18-65
  • Less than 16 years of education
  • Able to understand, and sign consent
  • Smoke >4 cigarettes/day for at least a year
  • No quit attempt in prior 1 month and not planning to quit smoking within next 6 months
  • Plan to live in local area for next 8 months
  • Able to read and write in English
  • Women not pregnant and taking steps to avoid pregnancy

Exclusion Criteria

  • College graduate
  • Use of psychotropic drugs
  • Significant medical condition, or immune system disorders, respiratory diseases, kidney or liver diseases or any other medical disorders that may affect biomarker data
  • Use of any non-cigarette nicotine delivery product in the past week or smoking cessation medicine in prior 3 months
  • Currently pregnant or nursing
  • Uncontrolled serious psychotic illness or substance abuse
  • History of difficulties providing blood samples-fainting, poor veins, anxiety
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01928719). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search